封面
市場調查報告書
商品編碼
1701250

美國病人參與解決方案市場規模、佔有率、趨勢分析報告:按類型、產品類型、功能、最終用途、國家/地區、細分預測,2025 年至 2030 年

U.S. Patient Engagement Solutions Market Size, Share & Trends Analysis Report By Type, By Delivery Type, By Functionality, By End Use, By Country, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 149 Pages | 商品交期: 2-10個工作天內

價格

美國病人參與解決方案市場成長與趨勢:

根據Grand View Research, Inc.的最新報告,美國病人參與解決方案市場規模預計到2030年將達到224.1億美元,2025年至2030年期間的複合年成長率為19.77%。

推動市場成長的關鍵因素包括醫療保健數位化的提高、慢性病的流行、患者的接受度以及 COVID-19 大流行。

新冠疫情成為商業和經濟快速變革的催化劑。某些在過去幾十年中穩步成長的趨勢,例如數位醫療解決方案,由於封鎖要求遠端工作和對技術的大量依賴,已出乎意料地變得無處不在。此外,COVID-19 疫情表明,臨床醫生快速、完整地了解患者的病歷對於就患者的護理做出最佳明智決策至關重要。這促進了市場的成長。

例如,2020 年 2 月,SolutionReach 宣布推出 SR Health,這是一個針對醫院、健康系統和企業醫療保健組織的基於人工智慧的病人參與平台。隨後,該公司於 2021 年 1 月增加了疫苗分發通訊,作為其 COVID-19 通訊解決方案的一部分。 60歲以上人口眾多是美國病人參與解決方案市場的主要動力。這是因為老年人的免疫力水平較低,更容易患肥胖症、心臟病和癌症等慢性疾病。

事實上,根據美國人口普查局的數據,到 2060 年,美國人口中位數預計將達到 43 歲,這意味著每 2.5 名工作年齡成年人對應一名退休人員。這表明,隨著美國老化,人們更有可能接受最好的治療以延長壽命。儘管美國治療方法,但慢性病的盛行率仍在上升。儘管美國治療方法,但慢性病的發生率也在上升。

據美國疾病管制與預防中心稱,慢性病是導致殘疾和死亡的主要原因,也是美國12 個月醫療保健費用高達 3.8 兆美元的主要原因。 COVID-19 疫情加速了對數位解決方案的需求,並凸顯了遠距醫療的必要性。行動平台的日益普及,加上不間斷的 3G、4G 網路和新興 5G 技術的廣泛普及,正在迅速推動行動醫療的使用。

此外,美國醫生使用行動電話和網路的人數也​​出現了驚人的成長,從而推動了行動醫療解決方案的發展。事實證明,使用行動應用程式在傳播慢性病知識、管理個人健康、與醫療保健提供者溝通、管理健康記錄等方面非常有效。預計這將推動市場成長。

美國病人參與解決方案市場報告重點

  • 在人工智慧、機器學習和遠端醫療的推動下,美國市場經歷了高水準的創新。例如,2024 年 8 月,醫療保健體驗測量和資料分析提供者 Press Ganey 宣布擴展其 PX Connect Suite,使醫療保健組織能夠直接在 Epic 中捕獲患者反饋並採取行動。
  • 預計人工智慧主導的參與部分將在 2024 年佔據最大的收入佔有率,達到 30.54%,並以最快的複合年成長率擴張,這得益於其個性化護理和增強患者與提供者之間互動的能力。
  • 預計到 2024 年,雲端基礎的領域將佔據市場主導地位,收益佔有率將達到 67.38%,並且預計將以最快的複合年成長率擴張。造成這種情況的因素包括遠端醫療的日益普及、對遠端患者監護的需求不斷增加以及向基於價值的照護模式的轉變。
  • 2024 年,通訊增強部分佔據了最大的收益佔有率。醫療保健領域擴大採用人工智慧主導的解決方案,這推動了對先進通訊功能的需求。
  • 醫療保健提供者部門在 2024 年佔據了最大的收益佔有率。醫療保健提供者治療的患者數量最多,並且是從一般護理到專科護理等各種健康問題的主要接觸點,這使他們成為病人參與解決方案的領先採用者。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章市場變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場趨勢與展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 案例研究
  • 法律規範
    • 產業分析-波特五力分析:製藥業
    • 波特五力分析
    • 依因素(政治/法律、經濟、社會、技術)進行 PEST 分析
    • COVID-19影響分析

第4章美國病人參與解決方案市場:類型估計和趨勢分析

  • 美國病人參與解決方案市場:類型變化分析
  • 美國病人參與解決方案市場:類型細分儀表板
  • 2024 年和 2030 年類型趨勢和市場佔有率分析
  • 按類型
  • 人工智慧驅動的參與
  • 遠端醫療解決方案
  • 患者門戶網站
  • 遠端患者監護
  • 人口健康管理
  • 預約和藥物提醒
  • 其他

第5章。美國病人參與解決方案市場:按產品類型和趨勢分析進行估計

  • 美國病人參與解決方案市場:產品類型變化分析
  • 美國病人參與解決方案市場:產品類型細分儀表板
  • 2024 年和 2030 年產品類型趨勢和市場佔有率分析
  • 依產品類型
  • 雲端基礎
  • 本地

第6章美國病人參與解決方案市場:能力評估與趨勢分析

  • 美國病人參與解決方案市場:功能變異分析
  • 美國病人參與解決方案市場:功能性細分儀表板
  • 2024 年和 2030 年功能趨勢和市場佔有率分析
  • 按功能
  • 增強溝通
  • 病患教育
  • 預測分析
  • 精簡營運
  • 其他

第7章美國病人參與解決方案市場:最終用途估計與趨勢分析

  • 美國病人參與解決方案市場:最終用途差異分析
  • 美國病人參與解決方案市場:最終用途細分儀表板
  • 2024 年和 2030 年最終用途趨勢和市場佔有率分析
  • 按最終用途
  • 醫療保健提供者
    • 門診設施
    • 住院設施
  • 醫療保健付款人
    • 私人的
    • 公共
  • 製藥公司
  • 藥局
    • 獨立藥房(經認證的核子醫學藥房)
    • 當地藥房
    • 通訊藥房
    • 零售藥局
    • 數位藥房
    • 專業藥房
    • 中央填充藥房
    • 配藥房
    • 其他(替代配藥地點、封閉設施)

第8章競爭格局

  • 公司分類
  • 企業市場分析
  • 企業市場占有率分析
    • 夥伴關係/合作/聯盟
    • 推出新服務
    • 合併與收購
    • 其他
  • 公司簡介/列表
    • Cerner Corporation(Oracle)
    • NextGen Healthcare, Inc.
    • Epic Systems Corporation
    • Allscripts Healthcare, LLC
    • McKesson Corporation
    • ResMed
    • Koninklijke Philips NV
    • Klara Technologies, Inc.
    • CPSI, Ltd.
    • Experian Information Solutions, Inc.
    • athenahealth
    • Solutionreach, Inc.
    • IBM
    • MEDHOST
    • Nuance Communications, Inc.
Product Code: GVR-2-68038-427-7

U.S. Patient Engagement Solutions Market Growth & Trends:

The U.S. patient engagement solutions market size is anticipated to reach USD 22.41 billion in 2030 and is expected to grow at a CAGR of 19.77% from 2025 to 2030, according to a new report by Grand View Research, Inc. The key factors driving the market growth include rising digitalization in healthcare, the prevalence of chronic conditions, adoption by patients, and the COVID-19 pandemic.

The COVID-19 pandemic acted as a catalyst for rapid business and economic changes. Certain trends, which grew steadily in the past decades, including digital healthcare solutions, unexpectedly became omnipresent as lockdowns directed remote operations and large-scale reliance on technology. In addition, the COVID-19 pandemic has shown the importance for clinicians to have rapid and full access to a patient's history to make the best-informed decision about their care. This propelled the growth of the market.

For instance, in February 2020, Solutionreach, Inc. launched SR Health, an AI-based patient engagement platform for hospitals, health systems, and enterprise healthcare organizations. This was followed by the addition of vaccine distribution messaging as part of its SR Health COVID-19 Communications solution, in January 2021. A large population over the age of 60 is a key driver for the U.S. patient engagement solutions market. This is owing to lower immunity levels in the geriatric population and higher vulnerability to chronic conditions such as obesity, cardiac problems, and cancer.

In fact, as per the U.S. Census Bureau, the median age of the country's population is estimated to reach age 43 by 2060 with just two-and-a-half working-age adults for every retirement-age individual. This indicates an aging U.S. population that is more likely to avail the best possible treatments to increase life span. The incidence of chronic illnesses in the U.S. is also on the rise despite the availability of several effective therapies. The incidence of chronic illnesses in the U.S. is also on the rise despite the availability of several effective therapies.

Chronic ailments are the leading cause of disability & death and are the leading drivers of the country's USD 3.8 trillion 12-monthly healthcare costs, according to the CDC. The COVID-19 outbreak has expedited the necessity for digital solutions, highlighting the need for remote care, which is not only preferred but also essential. Increasing adoption of mobile platforms coupled with the dissemination of uninterrupted 3G, 4G networks, and emerging 5G technology, are rapidly boosting the use of mobile health.

Furthermore, there has been an incredible upsurge in the use of mobile phones and the internet by physicians in the U.S. leading to the progress of mobile health solutions. The usage of mobile applications has proven to be very effective in spreading awareness about chronic diseases, managing personal health, communicating with healthcare providers, and maintaining health records. This is expected to fuel the market growth.

U.S. Patient Engagement Solutions Market Report Highlights:

  • The U.S. market experienced high levels of innovation, driven by advancements in AI, machine learning, and telemedicine. For instance, in August 2024, Press Ganey, a healthcare provider of experience measurement and data analytics, announced an expansion of its PX Connect Suite, allowing healthcare organizations to capture and respond to patient feedback directly within Epic
  • The AI-driven engagement segment held the largest revenue share of 30.54% in 2024 and is anticipated to expand at the fastest CAGR due to its ability to personalize care and enhance patient-provider interactions
  • The web/cloud-based segment dominated the market in 2024 with a revenue share of 67.38% and is anticipated to expand at the fastest CAGR. Factors include the growing adoption of telehealth, increased demand for remote patient monitoring, and the shift to value-based care models
  • The enhanced communication segment held the largest revenue share in 2024. With the increasing adoption of AI-driven solutions in healthcare, the demand for advanced communication capabilities is growing
  • The healthcare providers segment held the largest revenue share in 2024. Providers handle the highest number of patients and serve as the main point of contact for a wide range of health issues, from general to specialized care, and are the primary adopters of patient engagement solutions

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
    • 1.4.6. Research Assumption
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Data Visualization
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. Objectives
    • 1.8.1. Objective - 1
    • 1.8.2. Objective - 2
    • 1.8.3. Objective - 3
  • 1.9. List of Secondary Sources
  • 1.10. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. U.S. Patient Engagement Solutions Market
    • 2.1.1. Market Snapshot
    • 2.1.2. Segment Snapshot
      • 2.1.2.1. Types segment outlook
      • 2.1.2.2. Delivery type segment outlook
      • 2.1.2.3. Functionality segment outlook
      • 2.1.2.4. End Use segment outlook
    • 2.1.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Shift toward patient-centered care
      • 3.3.1.2. Growing need to curb rising healthcare costs
      • 3.3.1.3. Rising initiatives by organizations
      • 3.3.1.4. The emergence of digital platforms and necessity for omnichannel approach
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Data privacy and ethical considerations
      • 3.3.2.2. Lack of Interoperability Among Healthcare Providers
    • 3.3.3. Market Opportunity Analysis
    • 3.3.4. Market Challenges Analysis
  • 3.4. Case Studies
  • 3.5. Regulatory Framework
    • 3.5.1. Industry Analysis - Porter's Five Forces Analysis:- Pharmacy
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. Porter's five forces analysis
    • 3.5.3. PEST Analysis by Factors (Political & Legal, Economic, Social, and Technology)
    • 3.5.4. COVID-19 Impact Analysis

Chapter 4. U.S. Patient Engagement Solutions Market: Type Estimates & Trend Analysis

  • 4.1. U.S. Patient Engagement Solutions Market: Type Movement Analysis
  • 4.2. U.S. Patient Engagement Solutions Market: Type Segment Dashboard
  • 4.3. Type Movement & Market Share Analysis, 2024 & 2030
  • 4.4. U.S. Patient Engagement Solutions Market Estimates & Forecast, by Type
  • 4.5. AI-Driven Engagement
    • 4.5.1. AI-driven engagement market, 2018 - 2030 (USD Million)
  • 4.6. Telehealth Solutions
    • 4.6.1. Telehealth Solutions market, 2018 - 2030 (USD Million)
  • 4.7. Patient Portals
    • 4.7.1. Patient Portals market, 2018 - 2030 (USD Million)
  • 4.8. Remote Patient Monitoring
    • 4.8.1. Remote Patient Monitoring market, 2018 - 2030 (USD Million)
  • 4.9. Population Health Management
    • 4.9.1. Population Health Management market, 2018 - 2030 (USD Million)
  • 4.10. Appointment and Medication Reminders
    • 4.10.1. Appointment and Medication Reminders market, 2018 - 2030 (USD Million)
  • 4.11. Others
    • 4.11.1. Others market, 2018 - 2030 (USD Million)

Chapter 5. U.S. Patient Engagement Solutions Market: Delivery Type Estimates & Trend Analysis

  • 5.1. U.S. Patient Engagement Solutions Market: Delivery Type Movement Analysis
  • 5.2. U.S. Patient Engagement Solutions Market: Delivery Type Segment Dashboard
  • 5.3. Delivery Type Movement & Market Share Analysis, 2024 & 2030
  • 5.4. U.S. Patient Engagement Solutions Market Estimates & Forecast, by Delivery Type
  • 5.5. Web/Cloud-Based
    • 5.5.1. Web/cloud-based market, 2018 - 2030 (USD Million)
  • 5.6. On-premise
    • 5.6.1. On-premise market, 2018 - 2030 (USD Million)

Chapter 6. U.S. Patient Engagement Solutions Market: Functionality Estimates & Trend Analysis

  • 6.1. U.S. Patient Engagement Solutions Market: Functionality Movement Analysis
  • 6.2. U.S. Patient Engagement Solutions Market: Functionality Segment Dashboard
  • 6.3. Functionality Movement & Market Share Analysis, 2024 & 2030
  • 6.4. U.S. Patient Engagement Solutions Market Estimates & Forecast, by Functionality
  • 6.5. Enhanced Communication
    • 6.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 6.6. Patient Education
    • 6.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 6.7. Predictive Analysis
    • 6.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 6.8. Streamlined Operations
    • 6.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 6.9. Others
    • 6.9.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)

Chapter 7. U.S. Patient Engagement Solutions Market: End Use Estimates & Trend Analysis

  • 7.1. U.S. Patient Engagement Solutions Market: End Use Movement Analysis
  • 7.2. U.S. Patient Engagement Solutions Market: End Use Segment Dashboard
  • 7.3. End Use Movement & Market Share Analysis, 2024 & 2030
  • 7.4. U.S. Patient Engagement Solutions Market Estimates & Forecast, by End Use
  • 7.5. Healthcare Providers
    • 7.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.5.2. Outpatient Facility
      • 7.5.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.5.3. Inpatient Facility
      • 7.5.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 7.6. Healthcare Payers
    • 7.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.6.2. Private
      • 7.6.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.6.3. Public
      • 7.6.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 7.7. Pharmaceutical Companies (Pharma)
    • 7.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 7.8. Pharmacy
    • 7.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.8.2. Independent Pharmacies (Nuclear Pharmacies)
      • 7.8.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.8.3. Community Pharmacies
      • 7.8.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.8.4. Mail-Order Pharmacies
      • 7.8.4.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.8.5. Retail Pharmacies
      • 7.8.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.8.6. Digital Pharmacies
      • 7.8.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.8.7. Specialty Pharmacies
      • 7.8.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.8.8. Central Fill Pharmacies
      • 7.8.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.8.9. Compounding Pharmacies
      • 7.8.9.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.8.10. Others (Alternate dispensing site, Closed door)
      • 7.8.10.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Company Market Position Analysis
  • 8.3. Company Share Analysis
    • 8.3.1. Partnership/Collaboration/Alliance
    • 8.3.2. New Service Launch
    • 8.3.3. Mergers & Acquisitions
    • 8.3.4. Others
  • 8.4. Company Profiles/Listing
    • 8.4.1. Cerner Corporation (Oracle)
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Service benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. NextGen Healthcare, Inc.
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Service benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Epic Systems Corporation
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Service benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Allscripts Healthcare, LLC
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Service benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. McKesson Corporation
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Service benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. ResMed
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Service benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Koninklijke Philips N.V.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Service benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Klara Technologies, Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Service benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. CPSI, Ltd.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Service benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Experian Information Solutions, Inc.
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Service benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. athenahealth
      • 8.4.11.1. Overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Service benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Solutionreach, Inc.
      • 8.4.12.1. Overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Service benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. IBM
      • 8.4.13.1. Overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Service benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. MEDHOST
      • 8.4.14.1. Overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Service benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. Nuance Communications, Inc.
      • 8.4.15.1. Overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Service benchmarking
      • 8.4.15.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. patient engagement solutions market revenue estimates and forecast, by types, 2018 - 2030 (USD Million)
  • Table 4 U.S. patient engagement solutions market revenue estimates and forecast, by delivery type, 2018 - 2030 (USD Million)
  • Table 5 U.S. patient engagement solutions market revenue estimates and forecast, by functionality, 2018 - 2030 (USD Million)
  • Table 6 U.S. patient engagement solutions market revenue estimates and forecast, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig 1. U.S. Patient Engagement Solutions Market Segmentation
  • Fig 2. Market research process
  • Fig 3. Information procurement
  • Fig 4. Primary research pattern
  • Fig 5. Market research approaches
  • Fig 6. Value chain based sizing & forecasting
  • Fig 7. QFD modelling for Market share assessment
  • Fig 8. Market formulation & validation
  • Fig 9. Market snapshot
  • Fig 10. Types segment outlook
  • Fig 11. Delivery Type segment outlook
  • Fig 12. Functionality segment outlook
  • Fig 13. End Use segment outlook
  • Fig 14. Competitive landscape
  • Fig 15. U.S. Patient Engagement Solutions Market: Market dynamics
  • Fig 16. U.S. Patient Engagement Solutions Market: Porter's analysis
  • Fig 17. U.S. Patient Engagement Solutions Market: PESTLE analysis
  • Fig 18. U.S. Patient Engagement Solutions Market: Types segment dashboard
  • Fig 19. U.S. Patient Engagement Solutions Market: Types movement share analysis
  • Fig 20. AI-Driven Engagement Market, 2018 - 2030 (USD Million)
  • Fig 21. Telehealth Solutions Market, 2018 - 2030 (USD Million)
  • Fig 22. Patient Portals Market, 2018 - 2030 (USD Million)
  • Fig 23. Remote Patient Monitoring Market, 2018 - 2030 (USD Million)
  • Fig 24. Population Health Management Market, 2018 - 2030 (USD Million)
  • Fig 25. Appointment and Medication Reminders Market, 2018 - 2030 (USD Million)
  • Fig 26. Others Market, 2018 - 2030 (USD Million)
  • Fig 27. U.S. Patient Engagement Solutions Market: Delivery Type segment dashboard
  • Fig 28. U.S. Patient Engagement Solutions Market: Delivery Type Movement Share Analysis
  • Fig 29. Web/Cloud-Based Market, 2018 - 2030 (USD Million)
  • Fig 30. On-premise Market, 2018 - 2030 (USD Million)
  • Fig 31. U.S. Patient Engagement Solutions Market: Functionality segment dashboard
  • Fig 32. U.S. Patient Engagement Solutions Market: Functionality Movement Share Analysis
  • Fig 33. Enhanced Communication Market, 2018 - 2030 (USD Million)
  • Fig 34. Patient Education Market, 2018 - 2030 (USD Million)
  • Fig 35. Predictive Analytics Market, 2018 - 2030 (USD Million)
  • Fig 36. Streamlined Operations Market, 2018 - 2030 (USD Million)
  • Fig 37. Others Market, 2018 - 2030 (USD Million)
  • Fig 38. U.S. Patient Engagement Solutions Market: End Use Segment Dashboard
  • Fig 39. U.S. Patient Engagement Solutions Market: End Use Movement Share Analysis
  • Fig 40. Healthcare Providers Market, 2018 - 2030 (USD Million)
  • Fig 41. Outpatient Facility Market, 2018 - 2030 (USD Million)
  • Fig 42. Inpatient Facility Market, 2018 - 2030 (USD Million)
  • Fig 43. Healthcare Payers Market, 2018 - 2030 (USD Million)
  • Fig 44. Private Market, 2018 - 2030 (USD Million)
  • Fig 45. Public Market, 2018 - 2030 (USD Million)
  • Fig 46. Pharmaceutical Companies (Pharma) Market, 2018 - 2030 (USD Million)
  • Fig 47. Pharmacy Market, 2018 - 2030 (USD Million) Market, 2018 - 2030 (USD Million)
  • Fig 48. Independent Pharmacies (Nuclear Pharmacies) Market, 2018 - 2030 (USD Million)
  • Fig 49. Community Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig 50. Mail-Order Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig 51. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig 52. Digital Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig 53. Specialty Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig 54. Central Fill Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig 55. Compounding Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig 56. Others (Alternate dispensing site, Closed door) Market, 2018 - 2030 (USD Million)
  • Fig 57. Company categorization
  • Fig 58. Company Market position analysis
  • Fig 59. Strategic framework